Literature DB >> 3042937

The impact of nutrition in cystic fibrosis: a review.

K J Gaskin1.   

Abstract

A high energy intake, compensating for malabsorption, and the energy cost of lung disease, lung infections, and the underlying metabolic abnormality, is required to ensure normal growth in patients with cystic fibrosis. This goal can be readily achieved by adherence to a high quantity, normally balanced diet (with 40% of the energy as triglycerides of long-chain fatty acids). In contrast, this goal cannot be reached in the majority of patients adhering to low-fat and thus low-energy-containing diets, which almost inevitably lead to malnutrition with wasting and stunting. The prevention of malnutrition may well have considerably enhanced the prognosis of patients at one clinic. Further work is needed to define the interrelationship of nutrition and lung disease, and to define the appropriate nutrient requirements induced by the lung disease per se, recurrent infections, and the underlying disease process.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042937     DOI: 10.1097/00005176-198811001-00004

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Normal growth in cystic fibrosis associated with a specialised centre.

Authors:  C E Collins; L MacDonald-Wicks; S Rowe; E V O'Loughlin; R L Henry
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Enzyme contents of pancreatic extract preparations. Are they optimal?

Authors:  S Maguire; M C Goodchild
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

3.  Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis.

Authors:  P Vic; S Ategbo; F Gottrand; V Launay; G A Loeuille; J C Elian; D Druon; J P Farriaux; D Turck
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

4.  [Nutrition in Cystic Fibrosis: as important as the pulmonary management].

Authors:  Fabíola Villac Adde
Journal:  Rev Paul Pediatr       Date:  2015-01-23

5.  Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study.

Authors:  G Borgo; P Gasparini; A Bonizzato; G Cabrini; G Mastella; P F Pignatti
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

Review 6.  Gender differences in bronchiectasis: a real issue?

Authors:  Celine Vidaillac; Valerie F L Yong; Tavleen K Jaggi; Min-Min Soh; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2018-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.